Eye drug company QLT signs option agreement to sell punctal plug delivery system

VANCOUVER – QLT Inc. (TSX:QLT) said Monday it has signed an option agreement with Mati Therapeutics Inc., a company associated with former QLT chief executive Robert Butchofsky, for its punctal plug drug delivery system.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.